These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32345124)

  • 1. An
    Sinha SK; Shakya A; Prasad SK; Singh S; Gurav NS; Prasad RS; Gurav SS
    J Biomol Struct Dyn; 2021 Jun; 39(9):3244-3255. PubMed ID: 32345124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of bioactive compounds from
    Sinha SK; Prasad SK; Islam MA; Gurav SS; Patil RB; AlFaris NA; Aldayel TS; AlKehayez NM; Wabaidur SM; Shakya A
    J Biomol Struct Dyn; 2021 Aug; 39(13):4686-4700. PubMed ID: 32552462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
    Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an
    Chikhale RV; Gurav SS; Patil RB; Sinha SK; Prasad SK; Shakya A; Shrivastava SK; Gurav NS; Prasad RS
    J Biomol Struct Dyn; 2021 Aug; 39(12):4510-4521. PubMed ID: 32568012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico screening of the effectiveness of natural compounds from algae as SARS-CoV-2 inhibitors: molecular docking, ADMT profile and molecular dynamic studies.
    Mohammed Ali HSH; Altayb HN; Bayoumi AAM; El Omri A; Firoz A; Chaieb K
    J Biomol Struct Dyn; 2023 Apr; 41(7):3129-3144. PubMed ID: 35253618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery.
    Arunkumar M; Gunaseelan S; Kubendran Aravind M; Mohankumar V; Anupam P; Harikrishnan M; Siva A; Ashokkumar B; Varalakshmi P
    J Biomol Struct Dyn; 2022; 40(19):8961-8988. PubMed ID: 34014150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chikhale RV; Sinha SK; Patil RB; Prasad SK; Shakya A; Gurav N; Prasad R; Dhaswadikar SR; Wanjari M; Gurav SS
    J Biomol Struct Dyn; 2021 Sep; 39(14):5033-5047. PubMed ID: 32579064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.
    Chikhale R; Sinha SK; Wanjari M; Gurav NS; Ayyanar M; Prasad S; Khanal P; Dey YN; Patil RB; Gurav SS
    Mol Divers; 2021 Aug; 25(3):1889-1904. PubMed ID: 33492566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
    Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
    J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stilbene-based natural compounds as promising drug candidates against COVID-19.
    Wahedi HM; Ahmad S; Abbasi SW
    J Biomol Struct Dyn; 2021 Jun; 39(9):3225-3234. PubMed ID: 32345140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an
    Khan RJ; Jha RK; Singh E; Jain M; Amera GM; Singh RP; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
    Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM
    J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An
    Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR
    Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Alazmi M; Motwalli O
    J Biomol Struct Dyn; 2021 Oct; 39(17):6761-6771. PubMed ID: 32762537
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Arumugam M; Shanmugavel B; Sellppan M; Pavadai P
    J Biomol Struct Dyn; 2024; 42(2):1072-1078. PubMed ID: 37139540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.